The activities of three peptidases, glycyl peptidase, y-glutamyl transpeptidase, and leucine aminopeptidase, were determined at regular intervals in the sera of 5I patients with myocardial infarction. The activity of glycyl peptidase rose significantly on the second or third day after infarction, while significant increase in y-glutamyl transpeptidase and leucine aminopeptidase occurred by the end of the first and second weeks, respectively. All three peptidases studied reached top values at the beginning of the third week and slowly decreased thereafter. Six weeks after myocardial infarction, however, their activities were still significantly increased. Starch gel electrophoretic studies performed at the time ofpeptidase maximal rise revealed two serum fractions with y-glutamyl transpeptidase activity: one occupied the region between fast a2-globulin and the P-globulins, the other migrated with the 3-lipoproteins. The increase in total leucine aminopeptidase activity was accompanied by intensification of the enzymatic fraction occupying the zone between the post-albumins andfast a2-globulin, and by the appearance of a new fraction located in the sector between fast a2-globulin and ,8-globulins. Though this pattern of distribution of both peptidases was a consistent finding after myocardial infarction, an identical pattern was observed in some cases ofhepato-biliary diseases. Clinical observations indicate that determination of serum peptidase activities, particularly that of y-glutamyl transpeptidase, may be a useful late enzymatic test for myocardial infarction.
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It has been noticed in our department that the serum y-glutamyl transpeptidase (GGTP) activity rises in some patients after myocardial infarction (Orlowski, I963) . Agostini, Ideo, and Stabilini (I965) showed that the serum enzyme activity was normal during the first days after infarction, reached maximum levels in the second week, and did not return to normal range until after 30 days. These obser- mal and raised levels of serum leucine aminopeptidase (LAP) activity were recorded after infarction (Vokurkova and Tovarek, I963 (Szewczuk, Mulczyk, and Szczeklik, I969) . The activities of the peptidases were expressed in international units (IU) as the number of ,tmoles of ,-naphthylamine or p-nitroaniline liberated in one minute in the assay conditions and were calculated per IooO The heterogeneity of the peptidases was studied by means of starch gel electrophoresis. After the electrophoretic separation of serum the active enzymatic fractions were visualized using histochemical techniques. GGTP fractions were localized by the method described previously (Orlowski and Szczeklik, 1967) , while fractions showing LAP activity were demonstrated by the method of Dubbs, Vivonia, and Hilburn (I96I). The sera of 20 patients were investigated. In the majority, electrophoretic separation was repeated several times at various stages of the disease.
Results
The measurements of serum GP, GGTP, and LAP activities in patients with myocardial infarction are summarzed in the Table. All three peptidases showed a frequent increase in activities after myocardial infarction. Mean serum GP levels were already significantly increased on the second or third day after infarction. Subsequently they rose steadily and reached maximal values in the third week. Between the fourth and sixth week the enzyme activity slowly decreased, but did not return to normal values.
In the majority of patients normal values of serum GGTP activity were recorded during the first 3 days after myocardial infarction. Out of 5I patients studied, only in IO was an increase of activity found in the early period of the disease. This group included 4 patients with congestive heart failure, 3 patients with chronic cholecystitis or liver cirrhosis, and 3 patients in whom severe praecordial pain had preceded for a few days admission to the hospital, thus making the exact time of coronary occlusion difficult to ascertain. After the first 3 to 4 days GGTP activity increased progressively till it reached peak values between the end of the second and the beginning of the third week. These high levels gradually fell over the following month, though 6 weeks after infarction the mean activity was still significantly higher than in normal subjects.
Serum LAP activity was within normal range in the first week after infarction. Only 3 patients with congestive heart failure had increased levels of the activity at that time. In the second week the activity of the enzyme was already significantly increased. It obvious increase of enzymatic activity in the second and third week after admission, the mean activities differing significantly from the normal values. The peak values reached by the enzyme in some of these patients were in the same range as those recorded in patients with myocardial infarction. Severe coronary insufficiency preceding for a few weeks acute coronary occlusion was also accompanied by a progressive increase in GGTP activity, which continued to rise after the infarction had occurred (Fig. I) . Contrary to GGTP, the activity of other peptidases was usually within normal limits in patients with acute coronary insufficiency. A rise in GP activity in this group was recorded in 2 out of I2 patients, and in that of LAP in i.
Separation of peptidases in starch gel electrophoresis After starch gel electrophoresis of normal serum, LAP appeared as a single component located in the sector between fast a2-globulin and post-albumin. This single component was also present in sera obtained from patients one week after infarc-tion when total LAP activity remained within normal range. Increase in total activity in the second and third weeks after infarction was accompanied by intensification of staining of the fast a2-globulin to post-albumin zone and by the appearance of a new band located in *the sector between fast a2-globulin to fglobulin. In some patients with much increased activity, an additional band was observed between the origin and ac2-macroglobulin. We have noticed, however, the presence of the same additional two bands with LAP activity in some patients with hepatobiliary ..diseases (Fig. 2) .
The visualization of zones of GGTP activity in sera with normal enzyme activity was difficult, and very faint zones could only occasionally be detected. Within a few days after myocardial infarction a distinct zone of activity appeared. It occupied the region be-4.ween fast a2-globulin and the fl-globulins. Its presence was a consistent finding in all patients who exhibited an increase in total GGTP activity by the end of the first week after infarction. In the second and third weeks of the disease, a further rise of total GGTP activity was followed by the appearance of a supplementary enzymatic zone which migrated with the #-lipoproteins (Fig. 3) .
Discussion
The results obtained indicate that the serum activity of all the three peptidases studied, i.e. namely GP, GGTP, and LAP, rises after 1hyocardial infarction. In patients without congestive heart failure or concomitant hepatobiliary disease, the GP activity has already significantly increased on the second or third day after infarction. The levels of the other two peptidases remain unchanged at this time. A sharp rise in the GGTP activity *,usually occurs between the 4th and 7th days after myocardial infarction, while significant ¶thanges in the mean LAP activity can be detected only by the end of the second week. The further course of the mean serum activities is fairly similar. They all reach the top levels at the beginning of the third week and ,slowly decrease thereafter. However, six weeks after infarction the mean activities of *!,e three peptidases are still significantly raised.
Deviations group.bmj.com on April 16, 2017 -Published by http://heart.bmj.com/ Downloaded from gression of the clinical symptoms of liver congestion was accompanied by a fall in the peptidases. Thus, in 2 out of 4 patients studied, the level of the peptidases was still significantly increased between the 2nd and 5th
weeks, but the values recorded at this time were lower than in the first days of infarction. In 2 other patients the enzyme values declined temporarily after clinical improvement of the heart performance and rose 2 weeks later.
The origin of the increased serum activity of GGTP and other peptidases in patients with myocardial infarction is not clear. Two organs, namely the liver and the heart, should be considered as possible sources of the raised serum peptidases in this disease. After the kidney and jejunal epithelium the liver and bile ducts are the tissues with the highest amounts of GGTP and other peptidases (Orlowski, I963; Naftalin et al., I969) . On the contrary, the human myocardium has only traces of peptidase activities. The serum level of GGTP rises significantly in many hepatobiliary diseases: this has proved to be a valuable aid in the diagnosis of these pathological conditions (Szczeklik, Orlowski, and Szewczuk, I96I; Gibinski, Szaton, and Maraszek, I963) . It may therefore be assumed that the disturbances in hepatic circulation occurring in myocardial infarction give rise to the activity of serum peptidases (Naftalin et al., I969) . Clinical observations, however, give little support for this hypothesis. Congestive right heart failure is not a common finding in myocardial infarction. In our material it was noted in 5 out of Si patients. It occurred in the early period of infarction, and not in the second or third week when serum peptidases usually reached the top values. Furthermore, the activity of other enzymes considered to reflect liver function, e.g. alkaline phosphatase, phosphohexoisomerase, and aldolase, were within normal range in several patients studied at the time of the maximal peptidase rise.
The present data do not permit the determination of the exact origin of the raised serum peptidases after infarction. We believe, however, that changes occurring in the heart muscle rather than in the liver should be considered as the cause of the phenomena under discussion (Szczeklik et al., I968 Clinical observations indicate that determination of the serum peptidases may be of value in confirming myocardial infarction. Of the peptidases studied, GGTP has proved to be most reliable in this respect. Its maximal activity was on the average eightfold higher than the mean activity in normal subjects, while GP and LAP only doubled their values. Furthermore, the typical late increase of GGTP was observed in over 8o per cent of patients with myocardial infarction, while the frequency of GP and LAP increase was much lower. In our patients we have not observed any relation between the rate of increase of serum peptidase activities and the size of the infarction or its site. Other authors have reported similar observations concerning serum GGTP in myocardial infarction (HedworthWhitty et al., I967). According to our experience, the course of serum peptidase activities seems to be of no prognostic value, since no distinct differences were noticed between the survivors of myocardial infarction and those patients who died.
Diseases other than myocardial infarction are also accompanied by a raised activity of the peptidases in the serum. In the overwhelming majority of patients, alterations in the serum peptidases reflect disorders of the liver and bile ducts. We hoped that studies on the heterogeneity of serum peptidases might help in differentiating between various pathological conditions leading to raised serum peptidase activities. The results obtained have not confirmed these assumptions. Though the presence of certain serum fractions with GGTP and LAP activities was a constant finding in patients with myocardial infarction, and their appearance followed a regular pattern, the diagnostic value of these observations is limited, since a similar pattern of distribution was found in some hepatobiliary diseases (Orlowski, and Szczeklik, i967 
